Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Il punto su

PDF

La sindrome da shock tossico in bambini con ustioni minori

Toxic Shock Syndrome in children with minor burns

Giulia Remaschi1, Federica D’Asta2, Martina Giacalone1, Sabrina Becciani1, Alessia Stival1, Enrico Pinzauti3, Simone Pancani3, Maurizio de Martino1, Luisa Galli1, Antonio Messineo2
1Dipartimento di Scienze della Salute, Università di Firenze
2Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino, Università di Firenze
3SODs Centro Ustioni e Chirurgia Plastica, Ospedale "Anna Meyer", Firenze

Novembre 2014

Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Suggerite dall'AI
Septic shock Shock settico Sindrome da shock tossico Staphylococcus aureus Streptococcus pyogenes Toxic shock syndrome
Leggi anche
EL Caso contributivo
Un caso di shock tossico stafilococcico in un'adolescente
Barazzoni M, Lazzerotti A, Amoroso A, Tealdo M · 2024 · 3 temi in comune
RI Schede AIFA
Linfadenite batterica acuta localizzata
· 2025 · 2 temi in comune
RI Pagine elettroniche
Un caso di shock tossico stafilococcico in un'adolescente
Barazzoni M, Lazzerotti A, Amoroso A, Tealdo M. · 2024 · 3 temi in comune
RI Schede AIFA
Impetigine/Erisipela/Cellulite
· 2025 · 2 temi in comune
EL I Poster degli specializzandi
Toxic shock syndrome
Conte M, Zanella G · 2021 · 2 temi in comune
Bibliografia
Bibliografia
  1. Young AE, Thornton KL. Toxic shock syndrome in burns: diagnosis and management. Arch Dis Child Educ Pract Ed 2007;92:ep97-100.
  2. White MC, Thornton K, Young AE. Early diagnosis and treatment of toxic shock syndrome in paediatric burns. Burns 2005;31:193-7.
  3. Edwards-Jones V, Shawcross SG. Toxic shock syndrome in the burned patient. Br J Biomed Sci 1997;54:110-7.
  4. Issa NC, Thompson RL. Staphylococcal toxic shock syndrome. Suspicion and prevention are keys to control. Postgrad Med 2001;110:55-6,59-62.
  5. Edwards-Jones V, Greenwood JE; Manchester Burns Research Group. What's new in burn microbiology? James Laing Memorial Prize Essay 2000. Burns 2003;29:15-24.
  6. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 2001;55:77-104.
  7. Trede NS, Castigli E, Geha RS, Chatila T. Microbial superantigens induce NF-kappa B in the human monocytic cell line THP-1. J Immunol 1993;150:5604-13.
  8. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis 2009;9:281-90.
  9. Schlievert PM, Blomster DA, Kelly JA. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Obstet Gynecol 1984;64:666-71.
  10. Edwards-Jones V, Childs C, Foster HA. A comparison of phenotypic properties of Staphylococcus aureus isolated from burned children and other patient groups. Burns 1996;22:384-9.
  11. Edwards-Jones V. Toxic shock syndrome: causes in people with burn wounds. Wounds uk 2006;2:66-73.
  12. Kass EH, Kendrick MI, Tsai YC, Parsonnet J. Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J Infect Dis 1987;155:812-5.
  13. Sarafian SK, Morse SA. Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis. J Med Microbiol 1987;24:75-81.
  14. Wong AC, Bergdoll MS. Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus. Infect Immun 1990;58:1026-9.
  15. Edwards-Jones V, Foster HA. Effects of silver sulphadiazine on the production of exoproteins by Staphylococcus aureus. J Med Microbiol 2002;51:50-5.
  16. Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 2003;124:1103-15.
  17. Llewelyn M, Sriskandan S, Terrazzini N, Cohen J, Altmann DM. The TCR V beta signature of bacterial superantigens spreads with stimulus strength. Int Immunol 2006;18:1433-41.
  18. Kotb M, Norrby-Teglund A, McGeer A, Green K, Low DE. Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience. Scand J Infect Dis 2003;35:665-9.
  19. Brown AP, Khan K, Sinclair S. Bacterial toxicosis/toxic shock syndrome as a contributor to morbidity in children with burn injuries. Burns 2003;29:733-8.
  20. Trop M, Zobel G, Roedl S, Grubbauer HM, Feierl G. Toxic shock syndrome in a scald burn child treated with an occlusive wound dressing. Burns 2004;30:176-80.
  21. Serour F, Stein M, Gorenstein A, Somekh E. Early burn related gram positive systemic infection in children admitted to a pediatric surgical ward. Burns 2006;32:352-6.
  22. Masaki F, Gozo N, Yuichi H, Takahiro S, Osamu M, Tsuneyuki Y. Fatal possible toxic shock syndrome in an adult following 15% scald burn. Burns 2004;30:181-4.
  23. Jarman A, Duggal A, Korus L, Tredget EE. Toxic shock syndrome in an adult burn patient. Burns 2007;33:1051-3.
  24. Hardern R, Cavanagh S. Toxic shock syndrome after burns in children. J Accid Emerg Med 1995;12:68-9.
  25. Frame JD, Eve MD, Hackett ME, et al. The toxic shock syndrome in burned children. Burns Incl Therm Inj 1985;11:234-41.
  26. Lund CC, Browder NC. The estimation of areas of burns. Surg Gynaecol Obstet 1944;79:352-58.
  27. American Burn Association. Burn Center Referral Criteria. .
  28. British Burn Association. National Burn Care Referral Guidance.
  29. Hartford CE, Kealey GP. Care of outpatient burns. In: Herndon DN. Total Burn Care. Third Ed. Saunders Elsevier, 2007:67-80.
  30. Dorai AA. Wound care with traditional, complementary and alternative medicine. Indian J Plast Surg 2012;45:418-24.
  31. Merz J, Schrand C, Mertens D, Foote C, Porter K, Regnold L. Wound care of the pediatric burn patient. AACN Clin Issues 2003;14:429-41.
  32. Childs C, Edwards Jones V, Dawson M, Davenport PJ. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in burned children. Burns 1999;5:473-6.
  33. Quan L, Morita R, Kawakami S. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children. Burns 2010;36:716-21.
  34. Bacha EA, Sheridan RL, Donohue GA, Tompkins RG. Staphylococcal toxic shock syndrome in a paediatric burn unit. Burns 1994;20:499-502.
  35. Johnson D, Pathirana PD. Toxic shock syndrome following cessation of prophylactic antibiotics in a child with a 2% scald. Burns 2002;28:181-4.
  36. Heywood AJ, al-Essa S. Toxic shock syndrome in child with only 2% burn. Lancet 1990;335:867.
  37. Centers Disease Control. Toxic-shock syndrome-United States. MMWR Morb Mortal Wkly Rep 1980;29:229-30.
  38. Chesney PJ, Davis JP, Purdy WK, Wand PJ, Chesney RW. Clinical manifestations of toxic shock syndrome. JAMA 1981;246:741-8.
  39. Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980;303:1429-35.
  40. Wharton M, Chorba TL, Vogt RT, Morse DL, Buehler JW. Case definition for public health surveillance. MMWR 1990;39:1-43.
  41. Blomqvist L. Toxic shock syndrome after burn injuries in children. Scand J Plast Reconstr Surg Hand Surg 1997;31:77-81.
  42. Cole RP, Shakespeare PG. Toxic shock syndrome in scalded children. Burns 1990;16:221-4.
  43. Parsonnet J. Case definition of Staphylococcal toxic shock syndrome: a proposed revision incorporating lab findings. In: Arbuthnott J, Furman B (Eds). Proceedings of the European Conference on Toxic Shock Syndrome. Series 229. London, UK: The Royal Society of Medicine Press Ltd, 1998.
  44. Staphylococcal infections. In: American Academy of Pediatrics. Red Book. Pacini (Ed), 2012:653-68.
  45. Darenberg J, Ihendyane N, Sjölin J, et al.; StreptIg Study Group. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37:333-40.
  46. Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999;28:800-7.
  47. Valiquette L, Low DE, McGeer AJ. Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest. Clin Infect Dis 2009;49:1377-9.
  48. Shah SS, Hall M, Srivastava R, Subramony A, Levin JE. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis 2009;49:1369-76.
  49. Edwards-Jones V, Dawson MM, Childs C. A survey into toxic shock syndrome (TSS) in UK burns units. Burns 2000;26:323-33.
  50. Egan WC, Clark WR. The toxic shock syndrome in a burn victim. Burns Incl Therm Inj 1988;14:135-8.